Brown Brothers Harriman & CO Global Blood Therapeutics, Inc. Transaction History

Brown Brothers Harriman & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$25.48 - $37.34 $58,604 - $85,882	-2,300 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$32.46 - $43.42 $11,361 - $15,197	-350 Reduced 13.21%	2,300 $81,000
Q1 2021 May 13, 2021	SELL	$38.94 - $50.85 $11,682 - $15,255	-300 Reduced 10.17%	2,650 $108,000
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $111,067 - $188,121	2,950 New	2,950 $128,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

Stay updated on Brown Brothers Harriman & CO with notifications on news.